InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Walbert Keli, Director. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 2 disclosures have been logged. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
17,051 shares
Common Stock
SEC:0001193125-26-224601·
17,051 shares
Common Stock
SEC:0001193125-26-224601:0·
2 of 2 declarations
About Walbert Keli
Keli Walbert is a Board Member at Apellis Pharmaceuticals, Inc. She brings significant expertise in corporate governance and strategy. In her role, Keli oversees operations and contributes to strategic decision-making for the company. Her experience in the pharmaceutical sector is an asset for Apellis.
